Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 5.75 USD -3.04%
Updated: May 29, 2024

Cytek Biosciences Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytek Biosciences Inc
Gross Profit Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Cytek Biosciences Inc
NASDAQ:CTKB
Gross Profit
$109.4m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Gross Profit
$17.2B
CAGR 3-Years
-2%
CAGR 5-Years
9%
CAGR 10-Years
11%
Danaher Corp
NYSE:DHR
Gross Profit
$25.6B
CAGR 3-Years
21%
CAGR 5-Years
23%
CAGR 10-Years
10%
Mettler-Toledo International Inc
NYSE:MTD
Gross Profit
$2.2B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
6%
Agilent Technologies Inc
NYSE:A
Gross Profit
$3.4B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Gross Profit
$5.3B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
14%

See Also

What is Cytek Biosciences Inc's Gross Profit?
Gross Profit
109.4m USD

Based on the financial report for Dec 31, 2023, Cytek Biosciences Inc's Gross Profit amounts to 109.4m USD.

What is Cytek Biosciences Inc's Gross Profit growth rate?
Gross Profit CAGR 3Y
28%

Over the last year, the Gross Profit growth was 8%. The average annual Gross Profit growth rates for Cytek Biosciences Inc have been 28% over the past three years .